business
Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months
Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months
Read full story on Yahoo Finance → More top storiesAlso covered by
LA Times
'Wall Street Whiz Kid' pleads to stock scams enabled by projections of Hollywood glitz
Investing.com
Stifel reiterates Buy rating on Trevi Therapeutics stock at $18
Investing.com
Avalo Therapeutics prices $375 million stock offering
Investing.com
Axsome Therapeutics COO Mark Jacobson sells $1.08m in stock
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop